Patent 9872923 was granted and assigned to NBE Therapeutics on January, 2018 by the United States Patent and Trademark Office.
A method of producing an immunoligand/payload conjugate can encompass conjugating a payload to an immunoligand by means of a sequence-specific transpeptidase, or a catalytic domain thereof.